Showing results (51-60 of 886) with videos related to

Sort By:
Pageof 89
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Science behind total androgen blockade: from gene to combination therapyF Labrie, A Bélanger, A Dupont, et al.
Clinical Endocrinology|January 1, 1986
Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogenR St-Arnaud, R Lachance, S J Kelly, et al.
Anticancer Research|March 1, 1994
Stratification of stage D2 prostate cancer patients by a disease aggressiveness score and its use in evaluating disease response and outcome to combination hormonal treatment (GnRH-A plus flutamide)M Koutsilieris, A Dupont, J Gomez, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case reportF Labrie, A Dupont, A Bélanger, et al.
The Journal of Urology|October 1, 1991
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostateA Dupont, L Cusan, J L Gomez, et al.
The Journal of Endocrinology|February 1, 1975
Distribution of radioactivity in the organs of the rat and mouse after injection of (125I)alpha-melanocyte-stimulating hormoneA Dupont, A J Kastin, F Labrie, et al.
The Prostate|May 1, 1994
Metastatic prostate cancer pulmonary nodules: beneficial effects of combination therapy and subsequent withdrawal of flutamideL Cusan, J L Gomez, A Dupont, et al.
Brain Research|March 9, 1981
Age-dependent changes in the beta-endorphin content of discrete rat brain nucleiN Barden, A Dupont, F Labrie, et al.
The American Journal of Medicine|May 1, 1992
Incidence of liver toxicity associated with the use of flutamide in prostate cancer patientsJ L Gomez, A Dupont, L Cusan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old menA Bélanger, B Candas, A Dupont, et al.
Pageof 89